FDA approves Zyclara Tianyin names new CFO, chief development officer FDA committee to review Qnexa New clinical trial will compare MS drugs FDA approves expanded use of Xifaxan BioScrip completes Critical Homecare Solutions acquisition Diamyd Medical receives orphan drug designation SVP product development and clinical operations FDA to have Genzyme plant inspected, reviewed FDA committee won't recommend approval for non-Hodgkin’s lymphoma treatment First Previous 203 204 205 206 207 Next Last